Sara R. Schoenfeld

The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.

K. Costenbader, S. Kasturi, Sara R. Schoenfeld, 2013, Seminars in arthritis and rheumatism.

Diagnosis and Management of Rare Immune-Related Adverse Events.

K. Reynolds, M. Dougan, M. Aronow, 2019, The oncologist.

Evaluation and management approaches for scleroderma lung disease

F. Castelino, Sara R. Schoenfeld, S. Schoenfeld, 2017, Therapeutic advances in respiratory disease.

Interstitial lung disease in scleroderma.

F. Castelino, Sara R. Schoenfeld, S. Schoenfeld, 2015, Rheumatic diseases clinics of North America.

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Eric A. Meyerowitz, Matthew J. Frigault, J. Stone, 2020, The New England journal of medicine.

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

A. Villani, R. Sullivan, G. Boland, 2021, Journal for ImmunoTherapy of Cancer.

Temporal trends and outcomes among patients admitted for immune-related adverse events: A single-center retrospective cohort study from 2011-2018.

A. Villani, R. Sullivan, A. Bardia, 2021, The oncologist.

Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: A tsunami is coming, but are we ready?

C. Channick, R. Sullivan, A. Bardia, 2018 .

Musculoskeletal rheumatic complications of immune checkpoint inhibitor therapy: A single center experience.

R. Sullivan, D. Lawrence, K. Reynolds, 2019, Seminars in arthritis and rheumatism.

Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.

M. Baron, J. Gordon, D. Khanna, 2020, Seminars in arthritis and rheumatism.

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy

R. Sullivan, T. Mayrhofer, U. Hoffmann, 2022, JACC. CardioOncology.

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

Eric A. Meyerowitz, J. Gelfand, P. Reeves, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.